Cilian AG Information

Cilian AG is an innovative biotechnology enterprise, which uses the unique abilities of Ciliates, a new class of production organisms, for the industrial production of therapeutic proteins. The company is working on production of vaccines, monoclonal antibodies as well as on oral enzyme preparation for the substitution therapy of pancreatic insufficiency. By using a new class of production organism (Ciliates) Cilian AG can design the production process substantially safer, more efficient and more cost-effective as this is currently possible for comparable proteins with mammalian cells. Moreover it is expected, that monoclonal antibodies can be developed and produced significantly more effective. Cilian is offering this unique technology as CIBEX-System to Pharma- and Biotech companies.

Website	http://www.cilian.de
Revenue	$10 million
Employees	6 (6 on RocketReach)
Founded	2001
Address	42 Johann-krane-weg, Münster 48149, DE
Phone	+49 4925 1620310
Fax	+49 251 6203116
Industry	Biotechnology, Biotechnology Research, Business Services General, Business Services, Science and Engineering, Pharmaceuticals, Genetics, Health Care, Life Science
Web Rank	27 Million
Keywords	Biotechnology, Therapeutic Proteins, Vaccines, Protein Production, Monoclonal Antibodies, Biologics, Bioprocessing, Biopharmaceutical, Biomanufacturing, Pharmaceutical Manufacturing, Cell Culture, Industrial Biotechnology, Recombinant Proteins, Innovative Medicines, Microbial Production, Drug Development, Upstream Processing, Downstream Processing
Competitors	Thermo Fisher Scientific, Agilent Technologies, PerkinElmer, Inc., Waters Corporation, Bruker, SHIMADZU CORPORATION, GE HealthCare, Merck Group, Roche, Bio-Rad Laboratories +37 more (view full list)
SIC	SIC Code 873 Companies, SIC Code 87 Companies
NAICS	NAICS Code 541 Companies, NAICS Code 541713 Companies, NAICS Code 5417 Companies, NAICS Code 54 Companies, NAICS Code 54171 Companies